Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
Price Target
Average
260.27%
Revenue Forecast
Estimate
91.39%
EBIT
Estimate
--103.93%
Net Income
Estimate
45.25%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
UroGen Pharma Ltd.
Wall Street analysts predict an average 1-year price target for URGN of $37 , with forecasts ranging from
a
low of
$22 to a high of $60 .
URGN Lowest Price Target
Wall Street Target
22 USD
114.22%
URGN Average Price Target
Wall Street Target
37 USD
260.27%
URGN Highest Price Target
Wall Street Target
60 USD
484.23%
REVENUE FORECAST
Revenue Forecast Chart URGN
EBIT FORECAST
EBIT Forecast Chart URGN
NET INCOME FORECAST
Net Income Chart URGN